| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
License revenue | ||||||||||||
0 | - | - | - | - | - | - | - | - | - | - | - | - |
Operating expenses: | ||||||||||||
Research and development | ||||||||||||
22,179 | 24,366 | 25,606 | 26,291 | 24,389 | 21,830 | 19,338 | 19,683 | 20,330 | 22,503 | 0 | 0 | 0 |
General and administrative | ||||||||||||
9,233 | 9,085 | 8,544 | 8,535 | 8,813 | 8,921 | 8,988 | 8,626 | 8,158 | 9,849 | 0 | 0 | 0 |
Total operating expenses | ||||||||||||
31,412 | 33,451 | 34,150 | 34,826 | 33,202 | 30,751 | 28,326 | 28,309 | 28,488 | 32,352 | 0 | 0 | 0 |
Loss from operations | ||||||||||||
-31,037 | -33,451 | -34,150 | -34,826 | -33,202 | -30,751 | -28,326 | -28,309 | -28,488 | -32,352 | 0 | 0 | 0 |
Interest income | ||||||||||||
299 | 313 | 401 | 449 | 452 | 447 | 358 | 270 | 197 | 170 | 0 | 0 | 0 |
Interest expense | ||||||||||||
28 | 23 | 22 | 21 | 20 | 19 | 0 | 0 | 0 | - | 0 | - | - |
Interest expense - related party | ||||||||||||
- | - | - | - | - | - | - | - | - | 121 | 0 | 0 | 0 |
Australian research and development incentives | ||||||||||||
142 | 132 | -303 | 3 | 185 | 756 | 1,051 | 1,713 | 1,964 | 1,715 | 0 | 0 | 0 |
Foreign currency gains (loss) | ||||||||||||
-907 | 126 | -334 | -503 | -649 | -835 | -679 | 357 | 147 | 759 | 0 | 0 | 0 |
Change in fair value of warrant liability | ||||||||||||
- | - | - | - | - | -7,284 | 0 | 0 | 0 | - | - | - | - |
Net loss | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net loss | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | -29,727 | 0 | 0 | 0 |
Net loss | ||||||||||||
- | - | -23,424 | -22,121 | - | -23,138 | 0 | 0 | 0 | - | - | - | - |
Dividend attributable to down round feature of warrants | ||||||||||||
303 | 359 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Dividend attributable to Series A & B convertible preferred stock | ||||||||||||
0 | - | - | - | - | - | - | - | - | - | - | - | - |
Series A & B convertible preferred stock - beneficial conversion feature | ||||||||||||
0 | - | - | - | - | - | - | - | - | - | - | - | - |
Accretion of preferred stock to redemption value | ||||||||||||
- | - | - | - | - | - | - | - | - | 244 | 0 | 0 | 0 |
Net loss attributable to common stockholders | ||||||||||||
-41,602 | -33,259 | -23,783 | -22,480 | -21,478 | -23,138 | -31,211 | -31,394 | -30,935 | -29,971 | 0 | 0 | 0 |
Net Loss Per Share | ||||||||||||
Basic (in dollars per share) | ||||||||||||
-0.55 | - | -0.33 | - | -0.47 | - | -0.45 | - | - | - | -0.73 | - | - |
Diluted (in dollars per share) | ||||||||||||
-0.55 | - | -0.33 | - | -0.47 | - | -0.55 | - | - | - | -0.73 | - | - |
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | ||||||||||||
Basic (in shares) | ||||||||||||
31,632 | - | 23,923 | - | 19,237 | - | 14,701 | - | - | - | 9,395 | - | - |
Diluted (in shares) | ||||||||||||
31,632 | - | 23,923 | - | 19,237 | - | 15,211 | - | - | - | 9,395 | - | - |
Net loss per share - basic and diluted (in dollars per share) | ||||||||||||
- | - | - | -0.37 | - | - | - | -0.50 | -0.85 | - | - | -0.74 | -1.39 |
Weighted average common shares outstanding - basic and diluted (in shares) | ||||||||||||
- | - | - | 22,906 | - | - | - | 14,691 | 12,449 | - | - | 9,392 | 6,945 |